Clinical Trial Update: IVIg Therapy for Patients With Idiopathic Cardiomyopathy and Endomyocardial Biopsy Proven High PVB19 Viral Load [Phase 1]

View source ↗

Summary

Clinical trial update on a Phase 1 study of intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and biopsy-proven high Parvovirus B19…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Heart Failure | Phase 1 | Status: UNKNOWN